Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine

The personalised vaccine has succeeded in a final-stage melanoma trial. Here’s how it works, when it could become available and why researchers hope the approach can be used against other cancers.

CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine

We haven't written up this one. Channel News Asia has the full story — the link below goes straight to it.

Read the original at channelnewsasia.com →

More in Health & Medicine

More from Friday 21 August →